Skip to Content

Hubei Hongyuan Pharmaceutical Co., China, 2022

GMP Audit Report

Company
Hubei Hongyuan Pharmaceutical Co.

Product(s)
Metronidazole

Country
China

Audit Year
2022


0.00 € 0.00 €
0.00 €